Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
17/12/2022 12:59 pm
Meta-level question: how do you evaluate evidence for selank when the human data is thin and most trials are small?
Forum consensus and published consensus diverged here about five years ago and never reconverged.
I have started logging dose, time, and sleep because otherwise the anecdote is just a mood.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
Vial content, sterility and reconstitution are three separate questions and the certificate answers about one of them.
The interesting question is not whether it works but for whom and at what cost.